Stefan Englert

1.1k total citations
34 papers, 721 citations indexed

About

Stefan Englert is a scholar working on Statistics and Probability, Oncology and Economics and Econometrics. According to data from OpenAlex, Stefan Englert has authored 34 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Statistics and Probability, 12 papers in Oncology and 8 papers in Economics and Econometrics. Recurrent topics in Stefan Englert's work include Statistical Methods in Clinical Trials (13 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Optimal Experimental Design Methods (7 papers). Stefan Englert is often cited by papers focused on Statistical Methods in Clinical Trials (13 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Optimal Experimental Design Methods (7 papers). Stefan Englert collaborates with scholars based in Germany, United States and Switzerland. Stefan Englert's co-authors include Klaus Hauer, Michael Schwenk, Meinhard Kieser, Bijan Najafi, Tania Zieschang, Jane Mohler, Gurtej S. Grewal, Peter P. Nawroth, Michel Beaugrand and Moritz Koch and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biometrics.

In The Last Decade

Stefan Englert

30 papers receiving 706 citations

Peers

Stefan Englert
Andy Lee United States
John Jen Tai Taiwan
Simon Brown United Kingdom
Yogeshwar Kalkonde United States
Stavros Nikolakopoulos Netherlands
Silvia Perra Italy
Shinobu Tatsunami Japan
Kyuwan Lee United States
Andy Lee United States
Stefan Englert
Citations per year, relative to Stefan Englert Stefan Englert (= 1×) peers Andy Lee

Countries citing papers authored by Stefan Englert

Since Specialization
Citations

This map shows the geographic impact of Stefan Englert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Englert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Englert more than expected).

Fields of papers citing papers by Stefan Englert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Englert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Englert. The network helps show where Stefan Englert may publish in the future.

Co-authorship network of co-authors of Stefan Englert

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Englert. A scholar is included among the top collaborators of Stefan Englert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Englert. Stefan Englert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Englert, Stefan, et al.. (2024). Principles for Defining Estimands in Clinical Trials—A Proposal. Pharmaceutical Statistics. 24(1). e2432–e2432. 2 indexed citations
2.
Siegel, Jonathan, et al.. (2024). Time‐to‐event estimands and loss to follow‐up in oncology in light of the estimands guidance. Pharmaceutical Statistics. 23(5). 709–727. 5 indexed citations
3.
Keene, Oliver N., et al.. (2023). Why estimands are needed to define treatment effects in clinical trials. BMC Medicine. 21(1). 276–276. 15 indexed citations
4.
Englert, Stefan, et al.. (2023). Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development. Pharmaceutical Statistics. 22(5). 921–937. 5 indexed citations
5.
Rauch, Geraldine, et al.. (2016). Adaptive Designs for Two Candidate Primary Time-to-Event Endpoints. Statistics in Biopharmaceutical Research. 8(2). 207–216. 3 indexed citations
6.
Stefanović, Stefan, Ingo Diel, Hans‐Peter Sinn, et al.. (2015). Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment. Annals of Surgical Oncology. 23(3). 757–766. 12 indexed citations
7.
Schwenk, Michael, Tania Zieschang, Stefan Englert, et al.. (2014). Improvements in gait characteristics after intensive resistance and functional training in people with dementia: a randomised controlled trial. BMC Geriatrics. 14(1). 73–73. 73 indexed citations
8.
Kieser, Meinhard & Stefan Englert. (2014). Performance of Adaptive Designs for Single-Armed Phase II Oncology Trials. Journal of Biopharmaceutical Statistics. 25(3). 602–615. 2 indexed citations
9.
Schwenk, Michael, Klaus Hauer, Tania Zieschang, et al.. (2014). Sensor-Derived Physical Activity Parameters Can Predict Future Falls in People with Dementia. Gerontology. 60(6). 483–492. 71 indexed citations
10.
Schwenk, Michael, Ilona Dutzi, Stefan Englert, et al.. (2014). An Intensive Exercise Program Improves Motor Performances in Patients with Dementia: Translational Model of Geriatric Rehabilitation. Journal of Alzheimer s Disease. 39(3). 487–498. 38 indexed citations
11.
Oikonomou, Dimitrios, Stefan Kopf, Zdenka Djuric, et al.. (2014). Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study. Cardiovascular Diabetology. 13(1). 137–137. 19 indexed citations
12.
Liesz, Arthur, Jan Purrucker, Markus Zorn, et al.. (2013). Stress Mediators and Immune Dysfunction in Patients with Acute Cerebrovascular Diseases. PLoS ONE. 8(9). e74839–e74839. 55 indexed citations
13.
Englert, Stefan & Meinhard Kieser. (2013). Optimal adaptive two‐stage designs for phase II cancer clinical trials. Biometrical Journal. 55(6). 955–968. 22 indexed citations
14.
Falk, Michael, et al.. (2012). A First Course on Time Series Analysis : Examples with SAS [Version 2012.August.01]. Online Publication Service of Würzburg University (Würzburg University). 1 indexed citations
15.
16.
Riechardt, Aline I., et al.. (2012). Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis. Acta Ophthalmologica. 90(8). e638–44. 28 indexed citations
17.
Domschke, Christoph, Ingo Diel, Stefan Englert, et al.. (2012). Prognostic Value of Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: A Long-term Follow-up Study. Annals of Surgical Oncology. 20(6). 1865–1871. 23 indexed citations
18.
Schwenk, Michael, et al.. (2012). Test–retest reliability and minimal detectable change of repeated sit-to-stand analysis using one body fixed sensor in geriatric patients. Physiological Measurement. 33(11). 1931–1946. 60 indexed citations
19.
Englert, Stefan & Meinhard Kieser. (2011). Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials. Biometrics. 68(3). 886–892. 14 indexed citations
20.
Bartram, H., W Scheppach, Stefan Englert, et al.. (1995). Effects of Deoxycholic Acid and Butyrate on Mucosal Prostaglandin E2 Release and Cell Proliferation in the Human Sigmoid Colon. Journal of Parenteral and Enteral Nutrition. 19(3). 182–186. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andy Lee Breakdown of academic impact, for papers by John Jen Tai Breakdown of academic impact, for papers by Simon Brown Breakdown of academic impact, for papers by Yogeshwar Kalkonde Breakdown of academic impact, for papers by Stavros Nikolakopoulos Breakdown of academic impact, for papers by Silvia Perra Breakdown of academic impact, for papers by Shinobu Tatsunami Breakdown of academic impact, for papers by Kyuwan Lee
Rankless by CCL
2026